Translating the Advanced Glycation End Products (AGEs) Knowledge into Real-world Nutrition Strategies

Overview

Journal Eur J Clin Nutr

Specialty Nutritional Sciences

Date 2021 Oct 22

PMID 34675400

Citations 5

Authors

Heitor O Santos

Nilson Penha-Silva

Affiliations

Soon will be listed here.

Abstract

Advanced glycation end products (AGEs) are glycated proteins or lipids derived from complex metabolic pathways involved in the pathophysiology of various diseases, especially diabetes and diabetes-related complications. These compounds are omnipresent in human life, with both endogenous and exogenous sources. Despite the well-elucidated disease mechanisms, little is known about the AGEs/nutrition nexus in the circles of clinical practice recommendations. This review seeks to translate the accumulated knowledge about the biochemistry and pathophysiology of AGEs into a nutritional intervention based on real-world prescriptions.

Citing Articles

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.

Csiha S, Hernyak M, Molnar A, Lorincz H, Katko M, Paragh G Biomedicines. 2025; 13(2).

PMID: 40002851 PMC: 11852413. DOI: 10.3390/biomedicines13020438.

Effects of low-carbohydrate diets, with and without caloric restriction, on inflammatory markers in adults: a systematic review and meta-analysis of randomized clinical trials.

Kazeminasab F, Miraghajani M, Khalafi M, Sakhaei M, Rosenkranz S, Santos H Eur J Clin Nutr. 2024; 78(7):569-584.

PMID: 38499791 DOI: 10.1038/s41430-024-01431-x.

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Salavatizadeh M, Soltanieh S, Kachouei A, Abdollahi Fallahi Z, Kord-Varkaneh H, Poustchi H Front Endocrinol (Lausanne). 2023; 14:1228072.

PMID: 37674617 PMC: 10478091. DOI: 10.3389/fendo.2023.1228072.

Editorial: Functional foods, supplements, and dietary approaches in sports and clinical nutrition.

Santos H, Forbes S, Gaman M Front Nutr. 2023; 10:1203477.

PMID: 37215222 PMC: 10196615. DOI: 10.3389/fnut.2023.1203477.

Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial.

Kord Varkaneh H, Salehi Sahlabadi A, Gaman M, Rajabnia M, Macit-Celebi M, Santos H Front Nutr. 2022; 9:948655.

PMID: 35958257 PMC: 9360602. DOI: 10.3389/fnut.2022.948655.

References

Castro J, El-Atat F, McFarlane S, Aneja A, Sowers J . Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003; 5(5):393-401. DOI: 10.1007/s11906-003-0085-y. View

Jha J, Banal C, Chow B, Cooper M, Jandeleit-Dahm K . Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxid Redox Signal. 2016; 25(12):657-684. PMC: 5069735. DOI: 10.1089/ars.2016.6664. View

Goldin A, Beckman J, Schmidt A, Creager M . Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006; 114(6):597-605. DOI: 10.1161/CIRCULATIONAHA.106.621854. View

Vlassara H, Striker G . AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol. 2011; 7(9):526-39. PMC: 3708644. DOI: 10.1038/nrendo.2011.74. View

Ostry A, Young M, Hughes M . The quality of nutritional information available on popular websites: a content analysis. Health Educ Res. 2007; 23(4):648-55. DOI: 10.1093/her/cym050. View

Storey K, Forbes L, Fraser S, Spence J, Plotnikoff R, Raine K . Diet quality, nutrition and physical activity among adolescents: the Web-SPAN (Web-Survey of Physical Activity and Nutrition) project. Public Health Nutr. 2009; 12(11):2009-17. DOI: 10.1017/S1368980009990292. View

Perrone A, Giovino A, Benny J, Martinelli F . Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxid Med Cell Longev. 2020; 2020:3818196. PMC: 7104326. DOI: 10.1155/2020/3818196. View

Gautieri A, Passini F, Silvan U, Guizar-Sicairos M, Carimati G, Volpi P . Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue. Matrix Biol. 2016; 59:95-108. DOI: 10.1016/j.matbio.2016.09.001. View

Yamagishi S, Nakamura K, Imaizumi T . Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2008; 1(1):93-106. DOI: 10.2174/1573399052952631. View

10.

Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N . Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun. 1996; 228(2):539-43. DOI: 10.1006/bbrc.1996.1695. View

11.

Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski J, Bononi A . ATP synthesis and storage. Purinergic Signal. 2012; 8(3):343-57. PMC: 3360099. DOI: 10.1007/s11302-012-9305-8. View

12.

McCommis K, Finck B . Mitochondrial pyruvate transport: a historical perspective and future research directions. Biochem J. 2015; 466(3):443-54. PMC: 4464838. DOI: 10.1042/BJ20141171. View

13.

Lorenzi M . The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2008; 2007:61038. PMC: 1950230. DOI: 10.1155/2007/61038. View

14.

Ramasamy R, Goldberg I . Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res. 2010; 106(9):1449-58. PMC: 2882633. DOI: 10.1161/CIRCRESAHA.109.213447. View

15.

Ramasamy R, Yan S, Herold K, Clynes R, Schmidt A . Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 2008; 1126:7-13. PMC: 3049155. DOI: 10.1196/annals.1433.056. View

16.

Luevano-Contreras C, Chapman-Novakofski K . Dietary advanced glycation end products and aging. Nutrients. 2012; 2(12):1247-65. PMC: 3257625. DOI: 10.3390/nu2121247. View

17.

Schmidt A, Hasu M, Popov D, Zhang J, Chen J, Yan S . Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A. 1994; 91(19):8807-11. PMC: 44695. DOI: 10.1073/pnas.91.19.8807. View

18.

Horiuchi S, Higashi T, Ikeda K, Saishoji T, Jinnouchi Y, Sano H . Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes. 1996; 45 Suppl 3:S73-6. DOI: 10.2337/diab.45.3.s73. View

19.

Downs C, Dang V, Johnson N, Denslow N, Alli A . Hydrogen Peroxide Stimulates Exosomal Cathepsin B Regulation of the Receptor for Advanced Glycation End-Products (RAGE). J Cell Biochem. 2017; 119(1):599-606. PMC: 11632669. DOI: 10.1002/jcb.26219. View

20.

Turk N, Mornar A, Mrzljak V, Turk Z . Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria. Diabetes Metab. 2004; 30(2):187-92. DOI: 10.1016/s1262-3636(07)70106-4. View